Joby Aviation filed a prospectus supplement covering up to 2.42 million shares for potential resale by Strata Critical Inc. The company will not receive proceeds from any resale. Joby issued the shares to Strata Critical on 8 September after the acquired Blade Air Mobility operations met specific EBITDA milestones. These shares represent approximately 0.24% of Joby's 996.3 million shares outstanding. Separately, Joby's autonomous J208 aircraft has begun a month-long, 10-state coast-to-coast tour. The aircraft was displayed in Fort Worth at the launch of the White House-supported eVTOL and Advanced Air Mobility Integration Pilot Program. Joby shares reached a new 52-week low of $6.25 on Thursday, having declined 53.87% over the past 12 months.

Strata Critical Medical, a US provider of time-critical logistics solutions and specialised medical services to healthcare providers, is expected to break even within 12 months, according to consensus from two analysts. The company posted a US$33 million loss in its latest trailing 12 months, widening from US$27 million the previous year. Analysts forecast a final loss in 2025 before the company turns a US$7 million profit in 2026. This projection requires an aggressive average annual growth rate of 171%. Notably, Strata Critical Medical operates with no debt on its balance sheet, relying entirely on shareholder funding. This unusual structure for a cash-burning growth company reduces refinancing risks and makes it a less risky investment proposition.